background purpose european council directive health protection requires radiotherapy quality assurance programmes performance safety characteristics including acceptance repeated tests boron neutron capture therapy bnct high flux reactor hfr programme developed basis iec publications medical electron accelerators results fundamental differences clinical dosimetry medical electron accelerators bnct presented order magnitude dose components stability main influencing parameter 10b concentration bnct patient treatments comparison given requirements accelerators bnct units indicating items transferable equal additional preliminary results vivo measurements set 55mn 63cu 197au activation foils single fields fractions NUMBER treated patients NUMBER worse reproducibility used dose monitoring systems NUMBER caused influence hair position distance conclusions despite complex clinical dosimetry relevant dose components partly different linear energy transfer let bnct regulated following principles quality assurance procedures therapy medical electron accelerators reproducibility applied neutron fluence proportional absorbed doses main safety aspects equal teletherapy methods including bnct references NUMBER foil skull NUMBER NUMBER euratom petten nl